tldrdailynews.com logo

FDA accelerates approval process for generic biologics to reduce drug costs

1 min read
Source: CNN
FDA accelerates approval process for generic biologics to reduce drug costs
Photo: CNN
TL;DR

The FDA announced new measures to streamline the approval process for generic biological drugs, or biosimilars, aiming to reduce development costs and accelerate market entry, ultimately lowering drug prices and increasing access for Americans.

Topics:businesshealth#approval-process#biosimilars#drug-costs#fda#generic-biological-drugs#health
Share this article
  1. FDA to streamline approvals for generic biological drugs in latest move targeting health costs  CNN
  2. FDA plans to speed approvals of biosimilars  Axios
  3. FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs  CNBC
  4. US set to speed up approval for some generic drugs in blow to Big Pharma  Financial Times
  5. Watch live: RFK Jr., FDA chief give remarks on lowering drug prices  The Hill

Want the full story? Read the original reporting

Read on CNN